Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende Patientenratgeber
Erweiterte Suche
Anmelden
nach oben
Techniques in Coloproctology
Erschienen in:

02.05.2023 | Review

Does drinking coffee reduce the risk of colorectal cancer? A qualitative umbrella review of systematic reviews

verfasst von: S. H. Emile, S. H. Barsom, Z. Garoufalia, S. D. Wexner

Erschienen in: Techniques in Coloproctology | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Coffee drinking has been linked to many positive health effects, including reduced risk of some cancers. The present study aimed to provide an overview of the collective evidence on the association between coffee consumption and risk of colorectal cancer (CRC) through an umbrella review of the published systematic reviews.

Methods

This PRISMA-compliant systematic review of systematic reviews assessed the association between coffee drinking and the risk of CRC. An umbrella review approach was followed in a qualitative narrative manner. The quality of included reviews was assessed by the AMSTAR 2 checklist. The main outcome was the association between coffee drinking and CRC and colon and rectal cancer separately.

Results

Fourteen systematic reviews were included in this umbrella review. Coffee drinking was associated with a significant reduction in the risk of CRC according to five reviews (11–24%), colon cancer according to two reviews (9–21%), and rectal cancer according to one review (25%). One review reported a significant risk reduction of CRC by 7% with drinking six or more cups of coffee per day and another review reported a significant risk reduction of 8% with five cups per day reaching 12% with six cups per day. Decaffeinated coffee was associated with a significant risk reduction according to three reviews.

Conclusion

The evidence supporting caffeinated coffee as associated with a reduced risk of CRC is inconsistent. Dose-dependent relation analysis suggests that the protective effect of coffee drinking against CRC is evident with the consumption of five or more cups per day.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Higdon JV, Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46:101–123CrossRefPubMed
2.
Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J (2018) Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 360:k194 (Published correction appears in BMJ)
3.
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB (2014) Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 129:643–659CrossRefPubMed
4.
Malerba S, Turati F, Galeone C et al (2013) A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol 28:527–539CrossRefPubMed
5.
Park SY, Freedman ND, Haiman CA, Le Marchand L, Wilkens LR, Setiawan VW (2018) Prospective study of coffee consumption and cancer incidence in non-white populations. Cancer Epidemiol Biomarkers Prev 27:928–935CrossRefPubMedPubMedCentral
6.
Weinstein ND (1985) Reactions to life-style warnings: coffee and cancer. Health Educ Q 12:129–134CrossRefPubMed
7.
Zhao LG, Li ZY, Feng GS et al (2020) Coffee drinking and cancer risk: an umbrella review of meta-analyses of observational studies. BMC Cancer 20:101CrossRefPubMedPubMedCentral
8.
Marrett LD, Walter SD, Meigs JW (1983) Coffee drinking and bladder cancer in Connecticut. Am J Epidemiol 117:113–127CrossRefPubMed
9.
Simon D, Yen S, Cole P (1975) Coffee drinking and cancer of the lower urinary tract. J Natl Cancer Inst 54:587–591PubMed
10.
Sinha R, Cross AJ, Daniel CR et al (2012) Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 96:374–381CrossRefPubMedPubMedCentral
11.
Schmit SL, Rennert HS, Rennert G, Gruber SB (2016) Coffee consumption and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 25:634–639CrossRefPubMedPubMedCentral
12.
Sartini M, Bragazzi NL, Spagnolo AM et al (2019) Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective studies. Nutrients 11:694CrossRefPubMedPubMedCentral
13.
Kim Y, Lee J, Oh JH et al (2021) The association between coffee consumption and risk of colorectal cancer in a Korean population. Nutrients 13:2753CrossRefPubMedPubMedCentral
14.
Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097CrossRefPubMedPubMedCentral
15.
Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P (2015) Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc 13:132–140CrossRefPubMed
16.
Shea BJ, Reeves BC, Wells G et al (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358:j4008CrossRefPubMedPubMedCentral
17.
Bae JM (2020) Coffee consumption and colon cancer risk: a meta-epidemiological study of Asian cohort studies. Asian Pac J Cancer Prev 21:1177–1179CrossRefPubMedPubMedCentral
18.
Micek A, Gniadek A, Kawalec P, Brzostek T (2019) Coffee consumption and colorectal cancer risk: a dose-response meta-analysis on prospective cohort studies. Int J Food Sci Nutr 70:986–1006CrossRefPubMed
19.
Horisaki K, Takahashi K, Ito H, Matsui S (2018) A dose-response meta-analysis of coffee consumption and colorectal cancer risk in the Japanese population: application of a cubic-spline model. J Epidemiol 28:503–509CrossRefPubMedPubMedCentral
20.
Kashino I, Akter S, Mizoue T et al (2018) Coffee drinking and colorectal cancer and its subsites: a pooled analysis of 8 cohort studies in Japan. Int J Cancer 143:307–316CrossRefPubMed
21.
Gan Y, Wu J, Zhang S et al (2017) Association of coffee consumption with risk of colorectal cancer: a meta-analysis of prospective cohort studies. Oncotarget 8:18699–18711CrossRefPubMed
22.
Akter S, Kashino I, Mizoue T et al (2016) Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population. Jpn J Clin Oncol 46:781–787CrossRefPubMed
23.
Li G, Ma D, Zhang Y, Zheng W, Wang P (2013) Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutr 16:346–537CrossRefPubMed
24.
Tian C, Wang W, Hong Z, Zhang X (2013) Coffee consumption and risk of colorectal cancer: a dose-response analysis of observational studies. Cancer Causes Control 24:1265–1268CrossRefPubMed
25.
26.
Galeone C, Turati F, La Vecchia C, Tavani A (2010) Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control 21:1949–1959CrossRefPubMed
27.
Zhang X, Albanes D, Beeson WL et al (2010) Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst 102:771–783CrossRefPubMedPubMedCentral
28.
Je Y, Liu W, Giovannucci E (2009) Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 124:1662–1668CrossRefPubMed
29.
Giovannucci E (1998) Meta-analysis of coffee consumption and risk of colorectal cancer. Am J Epidemiol 147:1043–1052CrossRefPubMed
30.
31.
32.
Finucane MM, Stevens GA, Cowan MJ et al (2011) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377:557–567CrossRefPubMedPubMedCentral
33.
Moller JB, Pedersen M, Tanaka H et al (2014) Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians. Diabetes Care 37:796–804CrossRefPubMed
34.
Ivankovic S, Seibel J, Komitowski D, Spiegelhalder B, Preussmann R, Siddiqi M (1998) Caffeine-derived N-nitroso compounds. V. Carcinogenicity of mononitrosocaffeidine and dinitrosocaffeidine in bd-ix rats. Carcinogenesis 19:933–937CrossRefPubMed
35.
Ferruzzi MG (2010) The influence of beverage composition on delivery of phenolic compounds from coffee and tea. Physiol Behav 100:33–41CrossRefPubMed
36.
Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B (2002) Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 40:1155–1163CrossRefPubMed
37.
Gross G, Jaccaud E, Huggett AC (1997) Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol 35:547–554CrossRefPubMed
38.
Post SM, de Wit EC, Princen HM (1997) Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arterioscler Thromb Vasc Biol 17:3064–3070CrossRefPubMed
39.
Ricketts ML, Boekschoten MV, Kreeft AJ et al (2007) The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol 21:1603–1616CrossRefPubMed
Metadaten
Titel
Does drinking coffee reduce the risk of colorectal cancer? A qualitative umbrella review of systematic reviews
verfasst von
S. H. Emile
S. H. Barsom
Z. Garoufalia
S. D. Wexner
Publikationsdatum
02.05.2023
Verlag
Springer International Publishing
Erschienen in
Techniques in Coloproctology / Ausgabe 11/2023
Print ISSN: 1123-6337
Elektronische ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-023-02804-3

Weitere Artikel der Ausgabe 11/2023

Complete mesocolic excision versus standard resection for colon cancer: a systematic review and meta-analysis of perioperative safety and an evaluation of the use of a robotic approach

  • Review

Minimally invasive colectomies can be performed with similar outcomes to open counterparts for colorectal cancer emergencies: a propensity score matching analysis utilizing ACS-NSQIP

  • Original Article

Impact of imaging magnification on colorectal surgery: a matched analysis of a single tertiary center

  • Original Article

How do you manage the peritoneal opening during TAMIS procedure?

  • The Last Image

Segmental and extended resections provide comparable survival for clinically node-negative splenic flexure cancer: a propensity score-matched analysis of the National Cancer Database

  • Original Article

National implementation of an optimal standardised technique for right-sided colon cancer: protocol of an interventional sequential cohort study (Right study)

  • Open Access
  • Original Article

Neu im Fachgebiet Chirurgie

Verbände und Cremes gegen Dekubitus: „Wir wissen nicht, was sie bringen!“

Die Datenlage zur Wirksamkeit von Verbänden oder topischen Mitteln zur Prävention von Druckgeschwüren sei schlecht, so die Verfasser einer aktuellen Cochrane-Studie. Letztlich bleibe es unsicher, ob solche Maßnahmen den Betroffenen nutzen oder schaden.

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

US-Team empfiehlt Gastropexie nach Hiatushernien-Op.

Zur Vermeidung von Rezidiven nach Reparatur einer paraösophagealen Hiatushernie sollte einem US-Team zufolge der Magen bei der Op. routinemäßig an der Bauchwand fixiert werden. Das Ergebnis einer randomisierten Studie scheint dafür zu sprechen.

Mit Lidocain kommt der Darm nicht schneller in Schwung

Verzögertes Wiederanspringen der Darmfunktion ist ein Hauptfaktor dafür, wenn Patientinnen und Patienten nach einer Kolonresektion länger als geplant im Krankenhaus bleiben müssen. Ob man diesem Problem mit Lidocain vorbeugen kann, war Thema einer Studie.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise